The global Afatinib market size was valued at US$ 567.3 million in 2024 and is projected to reach US$ 782.6 million by 2030, at a CAGR of 5.5% during the forecast period 2024-2030.
United States Afatinib market size was valued at US$ 234.5 million in 2024 and is projected to reach US$ 317.8 million by 2030, at a CAGR of 5.2% during the forecast period 2024-2030.
Afatinib is a tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer with specific EGFR mutations.
Growth supported by increasing identification of EGFR mutations in lung cancer patients. Competition from newer generation EGFR inhibitors impacting market dynamics. Potential for expanded indications in clinical trials offering future growth prospects.
Report Overview
This report provides a deep insight into the global Afatinib market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Afatinib Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Afatinib market in any manner.
Global Afatinib Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Boehringer Ingelheim
- Hengrui Medicine
- Beacon Pharma
Market Segmentation (by Type)
- 30mg Tables
- 40mg Tables
- 50mg Tables
- 25mg Tables
- 20mg Tables
- Other
Market Segmentation (by Application)
- Hospital
- Clinic
- Drug Center
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Afatinib Market
- Overview of the regional outlook of the Afatinib Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Afatinib
1.2 Key Market Segments
1.2.1 Afatinib Segment by Type
1.2.2 Afatinib Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Afatinib Market Overview
2.1 Global Market Overview
2.1.1 Global Afatinib Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Afatinib Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Afatinib Market Competitive Landscape
3.1 Global Afatinib Sales by Manufacturers (2019-2024)
3.2 Global Afatinib Revenue Market Share by Manufacturers (2019-2024)
3.3 Afatinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Afatinib Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Afatinib Sales Sites, Area Served, Product Type
3.6 Afatinib Market Competitive Situation and Trends
3.6.1 Afatinib Market Concentration Rate
3.6.2 Global 5 and 10 Largest Afatinib Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Afatinib Industry Chain Analysis
4.1 Afatinib Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Afatinib Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Afatinib Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Afatinib Sales Market Share by Type (2019-2024)
6.3 Global Afatinib Market Size Market Share by Type (2019-2024)
6.4 Global Afatinib Price by Type (2019-2024)
7 Afatinib Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Afatinib Market Sales by Application (2019-2024)
7.3 Global Afatinib Market Size (M USD) by Application (2019-2024)
7.4 Global Afatinib Sales Growth Rate by Application (2019-2024)
8 Afatinib Market Segmentation by Region
8.1 Global Afatinib Sales by Region
8.1.1 Global Afatinib Sales by Region
8.1.2 Global Afatinib Sales Market Share by Region
8.2 North America
8.2.1 North America Afatinib Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Afatinib Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Afatinib Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Afatinib Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Afatinib Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Afatinib Basic Information
9.1.2 Boehringer Ingelheim Afatinib Product Overview
9.1.3 Boehringer Ingelheim Afatinib Product Market Performance
9.1.4 Boehringer Ingelheim Business Overview
9.1.5 Boehringer Ingelheim Afatinib SWOT Analysis
9.1.6 Boehringer Ingelheim Recent Developments
9.2 Hengrui Medicine
9.2.1 Hengrui Medicine Afatinib Basic Information
9.2.2 Hengrui Medicine Afatinib Product Overview
9.2.3 Hengrui Medicine Afatinib Product Market Performance
9.2.4 Hengrui Medicine Business Overview
9.2.5 Hengrui Medicine Afatinib SWOT Analysis
9.2.6 Hengrui Medicine Recent Developments
9.3 Beacon Pharma
9.3.1 Beacon Pharma Afatinib Basic Information
9.3.2 Beacon Pharma Afatinib Product Overview
9.3.3 Beacon Pharma Afatinib Product Market Performance
9.3.4 Beacon Pharma Afatinib SWOT Analysis
9.3.5 Beacon Pharma Business Overview
9.3.6 Beacon Pharma Recent Developments
10 Afatinib Market Forecast by Region
10.1 Global Afatinib Market Size Forecast
10.2 Global Afatinib Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Afatinib Market Size Forecast by Country
10.2.3 Asia Pacific Afatinib Market Size Forecast by Region
10.2.4 South America Afatinib Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Afatinib by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Afatinib Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Afatinib by Type (2025-2030)
11.1.2 Global Afatinib Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Afatinib by Type (2025-2030)
11.2 Global Afatinib Market Forecast by Application (2025-2030)
11.2.1 Global Afatinib Sales (Kilotons) Forecast by Application
11.2.2 Global Afatinib Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Afatinib Market Size Comparison by Region (M USD)
Table 5. Global Afatinib Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Afatinib Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Afatinib Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Afatinib Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Afatinib as of 2022)
Table 10. Global Market Afatinib Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Afatinib Sales Sites and Area Served
Table 12. Manufacturers Afatinib Product Type
Table 13. Global Afatinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Afatinib
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Afatinib Market Challenges
Table 22. Global Afatinib Sales by Type (Kilotons)
Table 23. Global Afatinib Market Size by Type (M USD)
Table 24. Global Afatinib Sales (Kilotons) by Type (2019-2024)
Table 25. Global Afatinib Sales Market Share by Type (2019-2024)
Table 26. Global Afatinib Market Size (M USD) by Type (2019-2024)
Table 27. Global Afatinib Market Size Share by Type (2019-2024)
Table 28. Global Afatinib Price (USD/Ton) by Type (2019-2024)
Table 29. Global Afatinib Sales (Kilotons) by Application
Table 30. Global Afatinib Market Size by Application
Table 31. Global Afatinib Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Afatinib Sales Market Share by Application (2019-2024)
Table 33. Global Afatinib Sales by Application (2019-2024) & (M USD)
Table 34. Global Afatinib Market Share by Application (2019-2024)
Table 35. Global Afatinib Sales Growth Rate by Application (2019-2024)
Table 36. Global Afatinib Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Afatinib Sales Market Share by Region (2019-2024)
Table 38. North America Afatinib Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Afatinib Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Afatinib Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Afatinib Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Afatinib Sales by Region (2019-2024) & (Kilotons)
Table 43. Boehringer Ingelheim Afatinib Basic Information
Table 44. Boehringer Ingelheim Afatinib Product Overview
Table 45. Boehringer Ingelheim Afatinib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Boehringer Ingelheim Business Overview
Table 47. Boehringer Ingelheim Afatinib SWOT Analysis
Table 48. Boehringer Ingelheim Recent Developments
Table 49. Hengrui Medicine Afatinib Basic Information
Table 50. Hengrui Medicine Afatinib Product Overview
Table 51. Hengrui Medicine Afatinib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Hengrui Medicine Business Overview
Table 53. Hengrui Medicine Afatinib SWOT Analysis
Table 54. Hengrui Medicine Recent Developments
Table 55. Beacon Pharma Afatinib Basic Information
Table 56. Beacon Pharma Afatinib Product Overview
Table 57. Beacon Pharma Afatinib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Beacon Pharma Afatinib SWOT Analysis
Table 59. Beacon Pharma Business Overview
Table 60. Beacon Pharma Recent Developments
Table 61. Global Afatinib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Global Afatinib Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. North America Afatinib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. North America Afatinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Europe Afatinib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 66. Europe Afatinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Asia Pacific Afatinib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 68. Asia Pacific Afatinib Market Size Forecast by Region (2025-2030) & (M USD)
Table 69. South America Afatinib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 70. South America Afatinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 71. Middle East and Africa Afatinib Consumption Forecast by Country (2025-2030) & (Units)
Table 72. Middle East and Africa Afatinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 73. Global Afatinib Sales Forecast by Type (2025-2030) & (Kilotons)
Table 74. Global Afatinib Market Size Forecast by Type (2025-2030) & (M USD)
Table 75. Global Afatinib Price Forecast by Type (2025-2030) & (USD/Ton)
Table 76. Global Afatinib Sales (Kilotons) Forecast by Application (2025-2030)
Table 77. Global Afatinib Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Afatinib
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Afatinib Market Size (M USD), 2019-2030
Figure 5. Global Afatinib Market Size (M USD) (2019-2030)
Figure 6. Global Afatinib Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Afatinib Market Size by Country (M USD)
Figure 11. Afatinib Sales Share by Manufacturers in 2023
Figure 12. Global Afatinib Revenue Share by Manufacturers in 2023
Figure 13. Afatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Afatinib Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Afatinib Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Afatinib Market Share by Type
Figure 18. Sales Market Share of Afatinib by Type (2019-2024)
Figure 19. Sales Market Share of Afatinib by Type in 2023
Figure 20. Market Size Share of Afatinib by Type (2019-2024)
Figure 21. Market Size Market Share of Afatinib by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Afatinib Market Share by Application
Figure 24. Global Afatinib Sales Market Share by Application (2019-2024)
Figure 25. Global Afatinib Sales Market Share by Application in 2023
Figure 26. Global Afatinib Market Share by Application (2019-2024)
Figure 27. Global Afatinib Market Share by Application in 2023
Figure 28. Global Afatinib Sales Growth Rate by Application (2019-2024)
Figure 29. Global Afatinib Sales Market Share by Region (2019-2024)
Figure 30. North America Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Afatinib Sales Market Share by Country in 2023
Figure 32. U.S. Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Afatinib Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Afatinib Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Afatinib Sales Market Share by Country in 2023
Figure 37. Germany Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Afatinib Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Afatinib Sales Market Share by Region in 2023
Figure 44. China Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Afatinib Sales and Growth Rate (Kilotons)
Figure 50. South America Afatinib Sales Market Share by Country in 2023
Figure 51. Brazil Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Afatinib Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Afatinib Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Afatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Afatinib Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Afatinib Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Afatinib Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Afatinib Market Share Forecast by Type (2025-2030)
Figure 65. Global Afatinib Sales Forecast by Application (2025-2030)
Figure 66. Global Afatinib Market Share Forecast by Application (2025-2030)
